SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001493152-20-020295
Filing Date
2020-11-02
Accepted
2020-11-02 13:02:57
Documents
70

Document Format Files

Seq Description Document Type Size
1 forms-1a.htm S-1/A 2901163
2 ex5-1.htm EX-5.1 17839
3 ex23-1.htm EX-23.1 3131
4 forms1a_001.jpg GRAPHIC 4599
5 forms1a_003.jpg GRAPHIC 4599
6 ex5-1_001.jpg GRAPHIC 5533
7 ex5-1_002.jpg GRAPHIC 2757
  Complete submission text file 0001493152-20-020295.txt   7037316

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE lixt-20200630.xml EX-101.INS 891856
9 XBRL SCHEMA FILE lixt-20200630.xsd EX-101.SCH 62199
10 XBRL CALCULATION FILE lixt-20200630_cal.xml EX-101.CAL 42211
11 XBRL DEFINITION FILE lixt-20200630_def.xml EX-101.DEF 279386
12 XBRL LABEL FILE lixt-20200630_lab.xml EX-101.LAB 346995
13 XBRL PRESENTATION FILE lixt-20200630_pre.xml EX-101.PRE 347100
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-248588 | Film No.: 201279762
SIC: 2834 Pharmaceutical Preparations